Niquitin Mini Mint (Nicotine)

Nicotine, the active ingredient in Niquitin Mini Mint, is a nicotine replacement therapy presented as a mini‑mint lozenge for oromucosal use. It delivers controlled nicotine to alleviate withdrawal symptoms, reduce cravings, and assist adult smokers in quitting tobacco use.

GNH USA supplies Niquitin Mini Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets. The company adheres to EU standards and provides reliable logistics for global distribution.

Niquitin Mini Mint is used in nicotine replacement therapy to address tobacco dependence. - Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms while quitting. - Relapse prevention: supports individuals who have stopped smoking to maintain abstinence. - Nicotine dependence: provides a controlled nicotine dose to replace cigarettes during a quit attempt.

Niquitin Mini Mint may cause a range of oral and systemic reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Throat discomfort: transient scratchy feeling after lozenge use. - Nausea: occasional upset stomach or queasiness. - Hiccups: brief episodes following administration. - Dizziness or light‑headedness. - Headache.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Chest pain or palpitations. - Severe mouth ulceration or bleeding. - Irregular heartbeat. - Persistent vomiting.

Before using Niquitin Mini Mint, consider the following safety measures. - Assess nicotine dependence level: determine appropriate strength and duration with a healthcare professional. - Review cardiovascular status: nicotine can increase heart rate and blood pressure. - Monitor for psychiatric conditions: nicotine may affect mood or anxiety. - Avoid use in uncontrolled hypertension or recent myocardial infarction. - Store at ambient temperature: keep below 25 °C, in the original pack, protected from moisture and direct sunlight.

Niquitin Mini Mint can interact with several medication classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - CYP2A6 inhibitors (e.g., methoxsalen): may raise nicotine plasma levels, increasing toxicity risk. - Monoamine oxidase inhibitors (MAOIs): combined use can potentiate hypertensive effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine‑induced tachycardia may be masked, requiring blood pressure monitoring. - Insulin or oral hypoglycemics: nicotine can affect glucose control, necessitating dose adjustments. - Antidepressants (especially SSRIs): may experience altered plasma concentrations; monitor therapeutic response.